key: cord-0855006-18vhels8 authors: Copot, Dana; Ionescu, Clara title: Tailored Pharmacokinetic model to predict drug trapping in long-term anesthesia date: 2021-05-21 journal: J Adv Res DOI: 10.1016/j.jare.2021.04.004 sha: eac9334db359a0245a7d828f6da63ff1d946cf26 doc_id: 855006 cord_uid: 18vhels8 Introduction In long-term induced general anesthesia cases such as those uniquely defined by the ongoing Covid-19 pandemic context, the clearance of hypnotic and analgesic drugs from the body follows anomalous diffusion with afferent drug trapping and escape rates in heterogeneous tissues. Evidence exists that drug molecules have a preference to accumulate in slow acting compartments such as muscle and fat mass volumes. Currently used patient dependent pharmacokinetic models do not take into account anomalous diffusion resulted from heterogeneous drug distribution in the body with time varying clearance rates. Objectives This paper proposes a mathematical framework for drug trapping estimation in PK models for estimating optimal drug infusion rates to maintain long-term anesthesia in Covid-19 patients. We also propose a protocol for measuring and calibrating PK models, along with a methodology to minimize blood sample collection. Methods We propose a framework enabling calibration of the models during the follow up of Covid-19 patients undergoing anesthesia during their treatment and recovery period in ICU. The proposed model can be easily updated with incoming information from clinical protocols on blood plasma drug concentration profiles. Already available pharmacokinetic and pharmacodynamic models can be then calibrated based on blood plasma concentration measurements. Results The proposed calibration methodology allow to minimize risk for potential over-dosing as clearance rates are updated based on direct measurements from the patient. Conclusions The proposed methodology will reduce the adverse effects related to over-dosing, which allow further increase of the success rate during the recovery period. Extremely long-term anesthesia, i.e. up to 4 weeks or more, has recently 33 been experienced in Covid-19 patients on life support machines [1, 2] . A high 34 risk of drug trapping in slow acting tissue metabolic rates such as muscle, bone 35 and fat has already been observed in moderate long-term anesthesia, i.e. above 36 two hours [3] . There is evidence to suggest that anomalous diffusion is in fact In this paper we provide a mathematical framework for drug trapping oc-77 curring in long term drug infusion in human slow uptake dynamics tissue (i.e. 78 fat) governed by multilayered dynamics and anomalous diffusion. This yields 79 added value with respect to current patient pharmacokinetic models which as-80 sume homogeneity and linear superposition dynamics. What we aim to achieve 81 is to justify the need for calibration of pharmacokinetic (PK) models used in 82 target controlled infusion for long term anesthesia. In this way, we facilitate to 83 counteract effects in Covid-19 patients as to drug accumulation in fat tissue and 84 lower the risk for over-dosing (which otherwise has undesirable side effects such 85 as prolonged recovery and increased morbidity). 3 This paper proposes a mathematical framework for drug trapping estimation 87 in PK models for estimating optimal drug infusion rates to maintain long-term 88 anesthesia in Covid-19 patients. We also propose a protocol for measuring and 89 calibrating PK models, along with a methodology to minimize blood sample 90 collection. By means of blood samples, the PK model can be realigned to newly 91 identified coefficients according to a heterogeneous uptake/clearance rates. This 92 is naturally linked to heterogeneus diffusion and fractal kinetics concepts [28, 29] . The paper is organized as follows: In Section 2 the material and methods 98 used in this study are presented. The context of research is presented followed 99 by the introduction of the mathematical models. Also the proposed method-100 ology is also described along with the patient benchmark used to perform the 101 simulations. In Section 3 the proposed calibration protocol is detailed. Section 102 4 discussed the obtained results followed by Section 6 were the conclusions of 103 this study are summarized. of fractional-order (FO) systems refers to those dynamical systems whose model 113 structure contains arbitrary order derivatives and/or integrals [31, 34] property is strongly dependent on history and the rate of (sub)diffusion of 125 molecules, involving chemotaxis and chemokinesis to create effects such as ad-126 hesion/cohesion among the commonly encountered nonlinear dynamic effects. In diffusion of drug molecules in human tissue, the inter-and intra-patient vari-128 ability commonly refers to these effects in terms of pharmacokinetic (PK) and 129 pharmakodynamic (PD) effects in the body. For long term drug infusion systems to maintain general anesthesia -e.g. In the plethora of nonlinear effects in sub-diffusive system dynamics, we focus 147 here on those related to non-uniform concentration distribution and determine 148 a transition probability factor linked to clearance rates between slow acting 149 PK compartmental models for patients undergoing anesthesia. The transition 150 probability from one compartment to another -say, for instance, from fat to Standard diffusion equation governing the particle density ρ(χ, t) is given by for ρ(χ, 0) = ρ 0 (χ) and D µ is a fractional diffusion constant (length 2 /time µ ) 157 and the Caputo derivative The spatial-time dependent drug concentration is governed by the fractional 159 Fokker-Planck equation: for c(χ, 0) = c 0 (χ) and F a constant external signal. However, drug infusion 161 varies in time, hence generalisation to time varying signals F (χ, t) is 162 ∂c(χ, t) for c(χ, 0) = c 0 (χ), and the 1 − µ the Riemann-Liouville fractional derivative: If spatial variations are introduced in (4) replacing µ → µ(χ, t), then for small where the reaction rate r 2 depends on the density of particles ρ 2 , and a is 193 here an input transport rate, for instance the rate at which the drug enters the 194 compartment. where: q 1 , q 2 and q 3 [mg] denotes the amount of drug in the three compart- The parameters of the pharmacokinetic models depend on age, weight, height 248 and gender [45] and can be calculated for Propofol as follows : where lbm represent the lean body mass, C l1 is the rate (called also clearance 252 rate) at which the drug is cleared from the body, C l2 and C l3 are the rates 253 at which the drug is removed from the central compartment to the other two 254 compartments by distribution. The lbm for man and women is calculated using the following expressions: The plasma amount of any type of drug depends on three processes: absorp-268 tion, distribution and elimination. These processes will make the amount of where: τ 1 , τ 2 and τ 3 represents the characteristic time for compartment 1, with: τ n1−1 The fractional operator n can be temporary and 288 locally different, however here we consider n 1 = n 2 = n 3 = n for maintaining 289 the mass balance, a generalized representation of (17) is given by: The main characteristic of fractional derivatives, more specifically derivatives where: t k = kh, (18) and it has the following form: Relations (20) constants (e.g. drug absorption and clearance rates). Moreover, these changes 459 in the PK model will also have an effect on the PD part (i.e. drug effect). Since standard dosing is based on such PK-PD models to indicate a target Thank you for allowing a resubmission of our manuscript, with an opportunity to address the reviewers' comments. We are uploading (a) our point-by-point response to the comments (below) (response to reviewers), (b) an updated manuscript with yellow highlighting indicating changes, and (c) a clean updated manuscript without highlights (PDF main document). We would like to thank the reviewers for their constructive feedback and their effort in reviewing our work. The revised version has tackled the suggestions to improve the quality of the work. We have addressed to our best knowledge each comment made by the reviewers and we hope to have answered them satisfactorily. The authors. I have read this paper in a detailed manner. Authors have studied on the propose a framework enabling calibration of the models during the follow up of Covid-19 patients undergoing anesthesia during their treatment and recovery period in ICU. They investigate the proposed model which easily updated with incoming information from clinical protocols on blood plasma drug concentration profiles. Their model and its methodology render to minimize risk for potential over-dosing as clearance rates are updated based on direct measurements from the patient. In this way, the adverse effects related to over-dosing are minimal, which allow further increase of the success rate during the recovery period. This paper is well written in English. But, there are some more modifications given as follows: We would like to thank the reviewer for the time and effort necessary to review our manuscript. Please find below the replies to every item. 1. Are the presented methods applicable for other different types of PDEs? Insert your answer in the conclusion section. Thank you for your remark. The presented method can be also applied to other types of PDEs. This has been included in the conclusion section. 2.It is better that, keywords should not include the words already used in the title of the manuscript. In the new version of the manuscript the keywords have been updated. 3.Introduction section must be improved after including few more theoretical details about the major concern of the manuscript. Thank you for the remark. The introduction section has been improved according to the suggestion provided by the reviewer. 4.They need to write in extend manner these papers [11, 12, 13, 14] in Introduction. Thank you, this is an important detail. We carefully referred those papers again with proper details in order to address this concern. 5.They need to present a comparision with these paper about COVID: Novel dynamical structures of 2019-nCoV with nonlocal operator via powerful computational technique, Biology, 9(5), 107; 2020;Chaos, Solitons and Fractals, 138 (109929), 1-6, 2020;Advances in Difference Equations, 2020(391), 1-11, 2020. Thank you for the remark, these papers have been studied and included in the new version of the manuscript. [24, 25, 26] 6.The conclusion section should be extended to explain the main motivation of this work. A more detailed conclusion section has been provided in the new version of the manuscript in order to better highlight the contribution of the presented work. This paper will be of value and interest to a significant portion of potential readers of the journal. Accordingly, it can be accepted for publication with minor revision. We would like to thank the Reviewer for the comment and for classification of the manuscript as needing minor revision. Title: Tailored Pharmacokinetic model for drug trapping in induced longterm anesthesia patients Article Type: SI: Fractional Calculus Models In the submitted manuscript, the authors proposed a framework enabling calibration of the models during the follow up of Covid-19 patients undergoing anesthesia during their treatment and recovery period in ICU. The proposed model can be easily updated with incoming information from clinical protocols on blood plasma drug concentration proles. Already available pharmacokinetic and pharmacodynamic models can be then calibrated based on blood plasma concentration measurements. This model and methodology allowed to minimize risk for potential over-dosing as clearance rates are updated based on direct measurements from the patient. In this way, the adverse effects related to over-dosing were minimal, which allowed further the increase of the success rate during the recovery period. Based upon my careful observation, the work and the presented results are novel and are of great importance to the widest audience. Therefore, it can be published subject to the following minor modifications/corrections/queries: We would like to thank the reviewer for the time and effort necessary to review our manuscript. Please find below the replies to every item. 1-About Highlights, Please consider: -Include 3 to 5 highlights. -There should be a maximum of 85 characters, including spaces, per highlight. -Only the core results of the paper should be covered. -Each item of the Highlights should be a sentence. Tailor existing PK model for long term anesthesia to account for drug trapping 2-Such a model would significantly reduce the risk of over-dosing 3-Calibrated PK model for general anesthesia 4-Improve patient's outcome in term of recovery period 5-Lower the risk of mortality 2-In the introduction, the authors did not provide a strong motivation of the paper and the obtained results. In addition, they should discuss the main contributions of their work in details after the motivation part. Then they should summarize the main structure of their paper in brief at the end of the introduction. Thank you for the remarks. The introduction section has been improved according to the suggestions made. 3-The English writing of the paper is required to be improved. Please check the manuscript carefully for typos and grammatical errors. The manuscript has been carefully revised to improve the grammar and readability. , the second author should be corrected as "A. Jajarmi" Thank you for the remark. We have corrected the error. The introduction needs to be improved by the recent developments in the field of the fractional calculus as well as its applications. For this purpose, the authors can add the following references to enrich the introductory section The ventila-488 tor management team: Repurposing anesthesia workstations and personnel 489 to combat covid-19 Response of chinese anesthesiologists to the 493 covid-19 outbreak Pharmacology and physiology in anesthetic prac-495 tice Advanced, pharmacokinetic models based on 497 organ clearance, circulatory, and fractal concepts Fractional velocity as a tool for the study of non-linear prob-500 lems Application of underdamped langevin dynamics sim-502 ulations for the study of diffusion from a drug-eluting stent Dynamics approach for multi-layer 505 mass transfer problems Sub-diffusive master equation with space-508 dependent anomalous exponent and structural instability A general approach to non-markovian compart-511 mental models An efficient algorithm for solving the 568 fractional optimal control of sirv epidemic model with a combination of 569 vaccination and treatment The role of fractional calculus in modelling fractional phenom-571 ena: a review, Communications in nonlinear science and numerical simula-572 tion Unique challenges in pediatric anesthesia 574 created by covid 19 An open source patient 577 simulator for design and evaluation of computer based multiple drug dosing 578 control foranesthetic and hemodynamic variables Fractional Calculus in Bioengineering Theory and applications of frac-583 tional differential equationsg Concepts, E. Ap-585 plications Recent history of fractional calculus Power law ivivc: an ap-589 plication of fractional kinetics for drug release and absorption A new approach to the compartmental 593 26 analysis in pharmacokinetics: fractional time evolution of diclofenac The human respiratory system: an analysis of the interplay be-596 tween anatomy, structure, breathing and fractal dynamics Fractional kinetics in drug absorption and 599 disposition processes 602 Evaluation of respiratory properties by means of fractional order models The random walk's guide to anomalous diffusion: a 605 fractional dynamics approach Transport equations for subdiffusion with nonlinear 607 particle interaction Numerical simulation of initial value problems with 609 generalized caputo-type fractional derivatives On the fractional optimal control prob-613 lems with a general derivative operator Gam-616 bus Influence of age and gender on the pharmacokinetics and phar-618 macodynamics of remifentanil: I. model development Data-driven modelling of drug tissue trapping using anomalous 621 kinetics Fractional kinetics in multi-623 compartmental systems A two-compartment 626 fractional derivative model for propofol diffusion in anesthesia Simulation of drug uptake in a two compartmental 629 fractional model for a biological system Numerical schemes for a class 632 of tempered fractional integro-differential equations Anesthesiologist in the loop and pre-635 dictive algorithm to maintain hypnosis while mimicking surgical distur-636 bance Models for nociception stimulation and mem-640 ory effects in awake and aware healthy individuals Bioimpedance sensor and methodology for acute pain monitoring Estimation of patient sensitivity 646 to drug effect during propofol hypnosis Diffusion through skin in the light of a fractional 651 derivative approach: progress and challenges Robust predictive control strategy applied for propofol dosing us-655 ing bis as a controlled variable during anesthesia Vivac-658 qua, Inversion-based propofol dosing for intravenous induction of hypnosis How to avoid unbounded drug accumulation with 662 fractional pharmacokinetics Modelling doxorubicin effect in var-665 ious cancer therapies by means of fractional calculus On the unphysical hypotheses 668 in pharmacokinetics and oral drug absoprtion: time to utilize instantaneous 669 rate coefficients instead of rate constants Density dependent 672 dispersal and population aggregation patterns of Health-System Pharmacists, Current Drug Shortages: Propofol 675 Emulsion Injection Drug-Shortage-Detail.aspx?id=651 Modeling and analysis of 679 covid-19 epidemics with treatment in fractional derivatives using real data 680 from pakistan Stationary distribution and extinction of 683 stochastic coronavirus (covid-19) epidemic model Fractal-fractional differentiation for the modeling 687 and mathematical analysis of nonlinear diarrhea transmission dynamics 688 under the use of real data Modeling attractors of chaotic dynamical systems 691 with fractal-fractional operators Analysis of series rl and rc circuits with 694 time-invariant source using truncated m, atangana beta and conformable 695 derivatives Between 2011-2016 she was the recipient of the prestigious Flanders Research Fund grant for postdoctoral fellows at the same university. Since October 2016 she is professor at Ghent University, teaching Computer Control of Industrial Processes within the Control and Automation Master Program She obtained her PhD degree at Ghent University in 2018 on modelling diffusion mechanisms in biological tissues. Currently she is the recipient of the prestigious Flanders Research Foundation grant for post-doctoral fellows at the same university After incorporating and answering the above suggestions and queries, the manuscript can be accepted for publication in JARE.We would like to thank the Reviewer for all the remarks and comments which have been carefully addressed in the new version of the manuscript. This paper investigates the existing compartmental modelling approaches and extended their usefulness by employing emerging tools from fractional calculus.The authors obtained a deterministic type of covid 19 model. The topic of this manuscript is meaningful in view of the dynamical analysis, and the methods and results are correct. So, this paper will be a useful contribution for the readers of this journal. Before acceptance, there are some comments/queries (major) that the authors should consider/respond:We would like to thank the reviewer for the time and effort necessary to review our manuscript. Please find below the replies to every item.1. Keywords should be other than title of the manuscript.In the new version of the manuscript the keywords have been updated.2. There are various grammatical errors throughout the manuscript. Authors should carefully read whole manuscript for fixing of the errors.The manuscript has been carefully revised to improve the grammar and readability.3. Punctuation symbols in mathematical formulas should be carefully checked.All equations have been checked and errors have been corrected. Thank you, this is an important detail. We updated the captions of each graph in the manuscript. Future directions should be included in the conclusion part of the manuscript with references of epidemiological and physical models recently formulated in viewpoint of fractional calculus. Such as: Thank you for the valuable suggestions. The proposed references have been included and described in the manuscript in the Discussion section, being also mentioned in the Conclusions section. What are the advantages of considering the deterministic model (9) in your study? 7. What are the major advantages of your research investigation for reducing the impact of the ongoing pandemic?One advantage is that the existing models do not take into account anomalous diffusion resulted from heterogeneous distribution in the body with varying clearance rates. Another advantage of the propose d model calibration protocol is that could give an indication of the potential overdosing as clearance rates are updated based on direct measurements for patients. This will automatically result in a increase rate of the recovery period.8. What is the particular conclusion that cannot be obtained via deterministic modeling thereby requiring fractional?In the investigated problem the clearance of hypnotic and analgesic drug from the body follows anomalous diffusion with afferent drug trapping and escape rates in heterogenous tissues. This means that there are different time constants for in and out parameters which will affect the decision of any control. It has been shown that fractional calculus can be an alternative theory that can describe the anomalous behavior [57,58,44..] 9. Improve length of conclusion section with inclusion of major findings and future directions as suggested above.Thank you for the remarks. In the new version of the manuscript the length of the Conclusion section has been improved accordingly. Thank you for the question. Indeed this item has not been discussed in the paper. The simulations were performed using the recent developed open source patient simulation for anesthesia and hemodynamic control which be downloaded here https://nl.mathworks.com/matlabcentral/fileexchange/85208-open-source-patient-simulator. Hence, the simulations in this paper are a cut-out from this. This has been included in the revised version of the paper and a short description of the simulator has been also included.The reviewer suggests that the manuscript would be accepted for publication if the authors can make MAJOR revision according to the above comments and queries. Waiting to read revised version of this manuscript.Author biography (for review paper only) • Tailor existing PK model for long term anesthesia to account for drug trapping • Such a model would significantly reduce the risk of over-dosing • Calibrated PK model for general anesthesia • Improve patient's outcome in term of recovery period • Lower the risk of mortality